EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Pro-Osteogenic Effect of the Nutraceutical BlastiMin Complex® in Women with Osteoporosis or Osteopenia: An Open Intervention Clinical Trial

Sofia Sabatelli, Emanuele-Salvatore Scarpa iD, Angelica Giuliani iD, Chiara Giordani iD, Jacopo Sabbatinelli iD, Maria Rita Rippo iD, Sara Cabodi, Barbara Petrini, Giancarlo Balercia, Gilberta Giacchetti

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25168565 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sofia Sabatelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, 60126 Ancona, Ita…. Hauptthemen laut MEDLINE: Bone Diseases, Metabolic, Dietary Supplements, Bone Density, Osteogenesis. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-POR MARCHE FESR 2014/2020, European Union—POR MARCHE FESR 2014/2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoporosis is a chronic disease that affects millions of patients worldwide and is characterized by low bone mineral density (BMD) and increased risk of fractures. Notably, natural molecules can increase BMD and exert pro-osteogenic effects. Noteworthily, the nutraceutical BlastiMin Complex® (Mivell, Italy, European Patent Application EP4205733A1) can induce differentiation of human bone marrow mesenchymal stem cells (BM-MSCs) in osteoblasts and can exert in vitro pro-osteogenic and anti-inflammatory effects. Thus, the purpose of this study was to verify the effects of BlastiMin Complex® on bone turnover markers (BTMs) and BMD in patients with senile and postmenopausal osteopenia or osteoporosis. The efficacy of BlastiMin Complex® on BTMs in serum was evaluated through biochemical assays. BMD values were analyzed by dual-energy X-ray absorptiometry (DXA) and Radiofrequency Echographic Multi Spectrometry (R.E.M.S.) techniques, and the SNPs with a role in osteoporosis development were evaluated by PCR. Clinical data obtained after 12 months of treatment showed an increase in bone turnover index, a decrease in C-reactive protein levels, and a remarkable increase in P1NP levels, indicating the induction of osteoblast proliferation and activity in the cohort of 100% female patients recruited for the study. These findings show that the nutraceutical BlastiMin Complex® could be used as an adjuvant in combination with synthetic drugs for the treatment of osteoporosis pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Diseases, MetabolicDietary SupplementsBone DensityOsteogenesisOsteoporosisHumansFemaleAgedMiddle AgedMesenchymal Stem CellsBiomarkersOsteoblastsBone Remodeling

Stichwörter der Autor:innen

BMDCRPCTXP1NPnutraceuticalsosteoblastsosteoporosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Clinic of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • R&D Department, Mivell S.r.l.s., 61032 Fano, Italy.
  • Department of Clinical and Molecular Sciences (DISCLIMO), Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Clinic of Laboratory and Precision Medicine, IRCCS Istituto Nazionale di Ricovero e Cura per Anziani (INRCA), 60126 Ancona, Italy.
  • R&D Department, Diatech Pharmacogenetics S.r.l., 60035 Jesi, Italy.
  • Division of Endocrinology, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, 60126 Ancona, Italy.

ORCID-Profile: Emanuele-Salvatore Scarpa, Angelica Giuliani, Chiara Giordani, Jacopo Sabbatinelli, Maria Rita Rippo

Förderung

  • European Union-POR MARCHE FESR 2014/2020
  • European Union—POR MARCHE FESR 2014/2020

Zitieren

APA

Sabatelli, S., Scarpa, E. S., Giuliani, A., Giordani, C., Sabbatinelli, J., Rippo, M. R., Cabodi, S., Petrini, B., Balercia, G., & Giacchetti, G. (2024). Pro-Osteogenic Effect of the Nutraceutical BlastiMin Complex® in Women with Osteoporosis or Osteopenia: An Open Intervention Clinical Trial. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168565

Vancouver

Sabatelli S, Scarpa ES, Giuliani A, Giordani C, Sabbatinelli J, Rippo MR, et al. Pro-Osteogenic Effect of the Nutraceutical BlastiMin Complex® in Women with Osteoporosis or Osteopenia: An Open Intervention Clinical Trial. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168565

BibTeX
@article{Sabatelli2024,
  author = {Sabatelli, Sofia and Scarpa, Emanuele-Salvatore and Giuliani, Angelica and Giordani, Chiara and Sabbatinelli, Jacopo and Rippo, Maria Rita and Cabodi, Sara and Petrini, Barbara and Balercia, Giancarlo and Giacchetti, Gilberta},
  title = {Pro-Osteogenic Effect of the Nutraceutical BlastiMin Complex® in Women with Osteoporosis or Osteopenia: An Open Intervention Clinical Trial},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25168565}
}
Kostenlos starten →